Parent Project Muscular Dystrophy
Overview
Parent Project Muscular Dystrophy is a non-profit organization that funds research and provides venture philanthropy grants to accelerate the development of therapies for Duchenne and Becker muscular dystrophy.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Myosana Therapeutics | Jun 2025 | Crowdfunding | Co-investor |
| Secretome Therapeutics | Mar 2026 | Grant | Co-investor |
| Myogenica, Inc. | Apr 2024 | Grant | Co-investor |
| MyoGene Bio | Nov 2025 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Donna Saccomanno
Co-Founder Board of Trustees
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Parent Project Muscular Dystrophy based?
Parent Project Muscular Dystrophy is headquartered in Washington D.C., United States.
When was Parent Project Muscular Dystrophy founded?
Parent Project Muscular Dystrophy was founded in 1994.
How many portfolio companies does Parent Project Muscular Dystrophy have?
Parent Project Muscular Dystrophy has 5 portfolio companies in Caplight's dataset.
What are some companies in Parent Project Muscular Dystrophy's portfolio?
Portfolio companies visible on Caplight include Myosana Therapeutics, Secretome Therapeutics, Myogenica, Inc., MyoGene Bio.
What was Parent Project Muscular Dystrophy's most recent investment shown here?
Parent Project Muscular Dystrophy's most recent investment in this portfolio sample was in Secretome Therapeutics in 2026.
What sectors does Parent Project Muscular Dystrophy focus on?
Parent Project Muscular Dystrophy focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Parent Project Muscular Dystrophy focus on?
Parent Project Muscular Dystrophy typically invests at the Early stage.